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Abstract
Essential tremor (ET) is a neurological disorder characterized by bilateral and symmet-
ric postural, isometric, and kinetic tremors of forelimbs produced during voluntary
movements. To date, only a single SCN4A variant has been suggested to cause ET. In
continuation of the previous report on the association between SCN4A and ET in a
family from Spain, we validated the pathogenicity of a novel SCN4A variant and its
involvement in ET in a second family affected by this disease. We recruited a Kurdish
family with four affected members manifesting congenital tremor. Using whole-
exome sequencing, we identified a novel missense variant in SCN4A, NM_000334.4:
c.4679C>T; p.(Pro1560Leu), thus corroborating SCN4A's role in ET. The residue is
highly conserved across vertebrates and the substitution is predicted to be patho-
genic by various in silico tools. Western blotting and immunocytochemistry per-
formed in cells derived from one of the patients showed reduced immunoreactivity
of SCN4A as compared to control cells. The study provides supportive evidence for
the role of SCN4A in the etiology of ET and expands the phenotypic spectrum of
channelopathies to this neurological disorder.
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1 | INTRODUCTION
Essential tremor (ET [MIM 190300]) is characterized by postural, isomet-
ric, and kinetic tremors that are visible and persistent and are restricted
to hands and forearms (Deuschl et al., 1998). It is rarely accompanied
with tremor of legs, but the tremor of the head develops in as many as
30–60% of the ET patients (Louis, 2013). While ET is not a fatal condi-
tion, it can be a major cause of social stigma, primarily affecting activities
of daily living such as writing, drinking, and eating (Louis, 2005).
The clinical presentation of ET overlaps with multiple disorders
such as Parkinson's disease (PD) and Dystonia and so on, and differen-
tial diagnosis is challenging to establish, especially at the earlier stages.
The clinical recommendations are periodically provided by the Tremor
Investigation Group (TRIG), the Movement Disorder Society (MDS), and
Washington Heights-Inwood Genetic Study of Essential Tremor
(WHIGET) (Bain et al., 2000; Deuschl et al., 1998; Louis et al., 1997).
The diagnosis is based on excluding other tremor types. These concor-
dantly exclude tremor produced due to dystonia, Parkinson disease,
hyperthyroidism, use of certain medicine or alcohol abuse as ET
(Deuschl et al., 1998). Resting tremor is traditionally associated with
Parkinson disease but action tremor is restricted to ET, however, resting
tremor can also be noted in severe forms of ET (Koller & Rubino, 1985).
The pathomechanism of ET is not completely understood. It has
been hypothesized to be either a neurodegenerative disorder of the
cerebellum or the manifestation of dynamic oscillatory disturbances
of neurologic origin (Deuschl & Elble, 2009).
ET is one of the most prevalent neurological disorder; a meta-
analysis of 28 different populations estimates 0.9% of pooled preva-
lence of all ages which increased to 4.9% in the age group ≥65 years
(Louis & Ferreira, 2010). The majority (50–70%) of ET cases is heredi-
tary (defined as two immediate family members diagnosed before
65 years of age) and familial cases presumably follow an autosomal
dominant mode of inheritance (Deuschl & Elble, 2009). OMIM cat-
alogued six ET loci termed ETM1–ETM6 (checked on September
14, 2021), but only five susceptibility genes—DRD3, HS1BP3, FUS,
TENM4, and NOTCH2NLC—have been characterized so far. These
were identified in ET families from diverse ethnic groups (Higgins
et al., 2005; Hor et al., 2015; Lucotte et al., 2006; Merner et al., 2012;
Sun et al., 2020). Among these, the latest report is the identification
of a tri-nucleotide (GGC) repeat expansion in the five prime
untranslated region (50-UTR) of NOTCH2NLC in two unrelated Chi-
nese families manifesting essential tremor (Sun et al., 2020). Notably,
molecular genetic defects of DRD3 and HS1BP3 could not be repli-
cated (Kuhlenbaumer et al., 2014; Zimprich, 2011). Furthermore, sev-
eral other genes (HTRA2, DNAJC13, SORT1, NOS3, KCNS2, HAPLN4,
and USP46) had been proposed to cause familial ET but their candi-
dacy was also not replicated (Liu et al., 2016; Rajput et al., 2015;
Sanchez et al., 2015; Unal Gulsuner et al., 2014). Recently, a missense
variant of SCN4A was reported to cause ET in five affected members
of a Spanish family. However, a second report supporting the link
between SCN4A and ET has been missing (Bergareche et al., 2015).
2 | MATERIALS AND METHODS
2.1 | Subjects
We recruited a consanguineous Kurdish family with four members of
the fourth and fifth generation diagnosed with ET (Figure 1a). The
study was carried out according to the rules described in the Declara-
tion of Helsinki. Prior to molecular analyses, we collected written
informed consent and got this study approved by the Ethics Commis-
sion of the National Institute for Biotechnology and Genetic Engineer-
ing (NIBGE), Faisalabad, Pakistan.
2.2 | Whole-exome sequencing
We used whole-blood to extract DNA using FlexiGene DNA kit
(Qiagen, 51206) from four members (IV-6, IV-7, V-1, and V2) of the
family. In case of probands, IV-5 and V-3, we extracted DNA from
primary fibroblasts and buccal smear using Quick Extract™ DNA
Extraction Solution (Lucigen, QE0905T) and Buccal-Prep Plus DNA
Kit (Bio-Budget Technologies GmbH, BPP-50), respectively. Whole-
exome sequencing (WES) was conducted on DNA samples of the
mother (IV-6) and her son (V-2) using NimbleGen SeqCap EZ Human
Exome Library v2.0 enrichment kit. Samples were run on an Illumina
HiSeq 2000 sequencing system (paired-end reads, 2 x 100 bp) and
data were analyzed as described before (Hussain et al., 2012). For var-
iant interpretation, we used VARBANK, our in-house database and
analysis platform (http://varbank.ccg.uni-koeln.de).
2.3 | Co-segregation analysis and variant
interpretation
The co-segregation analysis was performed by Sanger sequencing of
the targeted genomic region of SCN4A. Several in silico prediction
tools were used to predict the pathogenicity of SCN4A variant which
are given in Appendix S1 (Supplementary method section). For analyz-
ing the conservation status of proline at position 1560, sequences
retrieved from UniProtKB or NCBI were aligned by Clustal W.
To predict the consequences of the variant on the protein struc-
ture, we retrieved an X-ray structure of SCN4A protein (pdb-code
6agf, 3.2 A resolution) from the Protein Data Bank (www.rcsb.org).
We used PyMOL 2.3 (www.pymol.org; Schrödinger, LLC) for
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F IGURE 1 Clinical and molecular findings of ET family. (a) Five-generation pedigree of Kurdish family manifesting congenital essential tremor.
Asterisks shown on the top of each symbol mark individuals participating in this study. The genotype of SCN4A for each individual is shown
below each symbol. (b) Representation of the Archimedes spirals showing the magnitude of tremor of both hands in affected member (IV-6).
(c) Upper panel: schematics of genomic structure of SCN4A showing 24 exons, shown by vertical bars—filled for coding and unfilled for noncoding
exons. Black horizontal line shows intron drawn without scale. Scale bar for exon is indicated. Variant in red was identified in this study and in
black are previously reported ones. Lower panel: Schematic of sodium channel protein type 4 subunit alpha (SCN4A) drawn according to the
indicated scale. Variants identified for ET in this study and previously reported in Spanish family are shown by red and black colors, respectively,
placed below the image whereas those causing paramyotonia congenita of von Eulenburg and normokalemic and hyperkalemic periodic paralysis
are shown on the top of the structure. (d) Alignment of stretches of the SCN4A protein showing the conservation of mutated residues Pro1560,
Gly1537, Val1589, and Met1592 (boxed regions) in several species of vertebrates. (e) Three-dimensional structure of SCN4A (green) and subunit
β-1 (blue) complex (pdb-code 6agf). Left panel; schematic representation showing side view of the complex, middle panel; top view. Pro1560 is
shown in red whereas previously described variants are in black situated near the ion pore. Right panel; zoomed region of the complex showing
Pro1560 in space filling representation (red)
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structural analysis and WebLab viewerPro (Molecular Simulations Inc.)
for data visualization.
2.4 | Immunoblotting and immunofluorescence
To trace the amount and subcellular localization of SCN4A, we per-
formed immunoblotting and immunofluorescence, respectively, on der-
mal primary fibroblasts derived from the affected mother (IV-6) and her
elder healthy brother (IV-5) as control. The fibroblasts were propagated
using established protocols described elsewhere (Hussain et al., 2012).
For immunoblotting, we lysed the primary fibroblast cells in lysis buffer
having the following components; 50 mM Tris–HCl, pH 7.5, 150 mM
NaCl, 1% Nonidet P-40, 0.5% Na-deoxycholate, 0.1% SDS, with fresh
amount of Proteinase Inhibitor Cocktail (PIC, Sigma). Following to the
manual lysis of cells using 0.4  19 mm syringe having needle (needles
27G  3/400 , Nr.20, BD Macrolane TM3), samples were incubated on ice
for 15 min. After centrifugation, proteins in the supernatant were dena-
tured in SDS sample buffer, and subjected for western blot analysis.
To visualize SCN4A on immunoblots, anti-rabbit IgG peroxidase
coupled (Sigma A6154) secondary antibody (1:10,000 dilution) was
used to detect rabbit anti-SCN4A antibody (Abcam, ab138079) with
dilution of 1:200. As loading control, we used α-tubulin (rat monoclo-
nal anti Y/L1/2) (Hussain et al., 2012) as a primary (1:20) and anti-
mouse IgG peroxidase conjugated (Sigma, A4416) as secondary anti-
body (1:10,000 dilution). ImageJ was used to measure the band densi-
ties seen in western blot and were normalized with α-tubulin.
To investigate the effects of variant on subcellular localization of
SCN4A, we performed immunofluorescence. For this purpose, we grew
aforementioned primary fibroblasts overnight on 12 mm coverslips. The
following day, cells were incubated shortly with phosphate-buffered
saline (PBS). Immediately after removing PBS, the cells were fixed for
10 min with methanol (prechilled) at 20C. Prior to incubation with
primary antibody—rabbit anti-SCN4A (1:100, Abcam, ab138079)—
overnight at 4C, blocking was performed with 10% fetal bovine serum
(FBS) for 2 h at room temperature (RT). The following day, cells were
incubated thrice with PBS, each for 5 min, at RT. Secondary antibody,
Alexa Fluor 488 donkey anti-rabbit IgG (Invitrogen, A21206), dilution
1:10,000, was incubated along with 40 ,6-diamidino-20-phenylindole
(DAPI)—to stain DNA—for 30 min at room temperature in dark. After
incubation three times with 1 PBS, each for 5 min in dark, cells were
mounted on glass slides with gelvatol. To visualize, confocal laser
microscopy (Leica, LSM TCS SP5) was used. p value (Student's t test)
was calculated using t-test Calculator of GraphPad (https://www.
graphpad.com/quickcalcs/ttest1.cfm). Finally, Adobe Photoshop CS2
was used to prepare the composite images.
3 | RESULTS
3.1 | Clinical details of the patients
We present a family with congenital, nonprogressive essential tremor
and sudden excessive sweating in four members (Figure 1a). All the
affected members—age ranges from 9 months to 37 years—showed
slightly delayed motor development but normal intellect, vision and
hearing. None of the affected members had seizures. Our patients
never exhibited paralysis or muscular hypotonia or atrophy. In addi-
tion, they showed no clinical signs of myotonia of the hand, face and
tongue. Electromyography or electroencephalography was not per-
formed in any of the family members. Clinical detail of each our
patients is given below:
Case 1 (IV-6): Proband, 37-year-old, is fourth child of healthy consan-
guineous Kurdish parents. She had essential tremor since birth,
accompanied by sudden excessive sweating. The sweat episodes were
independent of whether the patient was at rest or in motion. She
exhibited bilateral posture as well as kinetic tremor of the whole body
and extremities increasing a slightly in arbitrary movements (Video
S1). She had no voice tremor. Her writing was irregular but readable.
In Archimedes Spiral Test (following a spiral shape with a pen), she
faced more difficulty following with her left hand than with her right,
which is her dominant hand (Figure 1b). The blood profile showed a
normal potassium level. She did not show any other cerebellar, rigid-
kinetic or dystonic symptoms, and was unremarkable for ectodermal
abnormalities, seizures, or psychiatric disease.
Case 2 (V-1): The female patient is 8-year-old and the first child of
IV-6. She had clinical presentation similar to her mother, such as non-
progressive essential tremor (Video S2) and sudden excessive sweat-
ing since birth. Skull sonography revealed normal cerebral structures
and normal sized cerebral ventricles. A Doppler sonography of the
anterior cerebral artery showed a normal flow profile without evi-
dence of increased intracranial pressure. She learned to walk upright
at the age of 17 months. She had average intellect and normal health
otherwise.
Case 3 (V-2): The male proband is the second child of IV-6, he learned
to walk upright at the age of 16 months. He also showed congenital
tremor similar to his mother (IV-6).
Case 4 (V-3): She is 9 months old and had congenital tremor like her
mother (IV-6), associated with sweat attacks. She was normally devel-
oped and no other health issues were recorded.
3.2 | Identification of the causal variant in SCN4A
In WES data of two affected individuals, we focused on heterozygous
variants that were shared by both individuals. We preferentially
searched for causative variants in genes implicated in the etiology of
ET, and found a missense variant in SCN4A, NM_000334.4:
c.4679C > T; p.(Pro1560Leu) (Figure 1c, upper panel). The gene was
previously reported for ET association in a Spanish family (Bergareche
et al., 2015). Sanger sequencing of all available family members
showed co-segregation of the variant (c.4679C>T) with the disease,
according to an autosomal dominant mode of inheritance (Figure 1a).
The variant is listed in gnomAD (rs753838641) with two heterozy-
gous alleles but it is absent in ClinVar and 2379 samples of our in-
house dataset. In silico analyses using several tools predicted patho-
genic effects of this variant on SCN4A (Table S1). It has a CADD score
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of 24.4 thus placed in the category of pathogenic variations
(Table S1). MuPro suggested decrease of SCN4A stability due to the
predicted substitution p.(Pro1560Leu) (Table S1).
3.3 | In silico analyses revealed the pathogenic
nature of the identified variant
SCN4A encodes sodium channel protein type 4 subunit alpha—a pore-
forming subunit of the sodium channel present in skeletal muscle,
which is a polypeptide of 1836 amino acids also known as voltage-
gated sodium channel subunit alpha Nav1.4 (Pan et al., 2018).
According to NCBI conserved domain databases, SCN4A has four ion
transport protein domains, a sodium ion transport-associated domain
situated within the middle of the protein and an inactivation gate of
the voltage-gated sodium channel alpha subunits. Our variant residue,
p.(Pro1560Leu), is located within the fourth ion transport protein
domain (Figure 1c, lower panel), in an extracellular sequence stretch
(pos. 1545-1574) situated between a pore-forming intramembrane
part and transmembrane helix (Pan et al., 2018). The altered and two
adjacent residues are strictly conserved (Figure 1d), depicting the
functional significance of these specific residues. Proline in protein
structures sits usually at positions where structural flexibility has to be
restricted, especially in β-turns where it enables a correct refold of the
polypeptide chain. In a cryo-EM structure of a complex consisting of
shorter fragments of SCN4A and channel subunit β1—encoded by
SCN1B—Pro1560 is located in a loop of SCN4A (Pan et al., 2018)
which makes close contact with the channel subunit β1 (Figure 1e). A
substitution by leucine keeps the hydrophobic character of the side
chain, but may have local structural consequences, where an ion chan-
nel with its tight filtering for a special ion and subtle structural
changes connected with the opening and closing of the channel may
confer malfunction. These structural changes could also impair the
interaction with subunit β1 (Figure 1e).
3.4 | Reduced expression of SCN4A
We next assessed the consequences of the SCN4A variant at the cel-
lular level. Immunoblotting of cell lysate from patient-derived primary
fibroblasts and those derived from a healthy individual indicated
reduced immunoreactivity of SCN4A in the patient (Figure 2a). The
comparison of band intensities and normalization with reference to
α-tubulin showed reduction of 56% of SCN4A in mutant cells as com-
pared to wild-type cells (Figure 2b). Immunofluorescence for SCN4A
in primary fibroblasts showed the expected localization at the cell
membrane (Pan et al., 2018) in both wild-type and mutant cells
(Figure 2c, upper panel), but the latter showed a weaker signaling
intensity (Figure 2c, lower panel). Thus, immunofluorescence analyses
corroborated the findings of the western blots showing a reduced
amount of the protein in mutant cells.
Taken together, we have provided compelling evidences, adding
to the likelihood for the involvement of SCN4A in the etiology of ET
by identifying a second variant in an unrelated family. Notably, we
have also provided supporting evidence for the pathogenicity of the
proposed variant at DNA and protein level.
4 | DISCUSSION
We report a Kurdish family manifesting congenital essential tremor
inherited in an autosomal dominant manner. Although, essential
tremor is well established as a neurological disorder of adult onset,
our family showed congenital tremor in all patients, that, to the best
of our knowledge, has never been reported before. Even in the Span-
ish family, harboring the other reported SCN4A variant, c.4609G>A;p.
Gly1537Ser (Figure 1c–e), affected members manifested tremor only
at the age of 23 at the earliest (Bergareche et al., 2015). Early-onset
tremor has been found to be associated with the familial form, while
later-onset tremor is associated with rapid disease progression
(Hopfner et al., 2016). Our study confirms the suggestion that youn-
ger age at onset of ET is mostly related to familial forms.
The patients were analyzed by WES of two patients from two dif-
ferent generations of this family. The variant of SCN4A, was selected
for initial segregation analysis due to previous report of this gene
linked with ET and epilepsy (Bergareche et al., 2015). Nevertheless,
we also explored other shared variants between both affected mem-
bers for their possible contribution to the pathogenesis of ET, but
none of them qualified due to very high allele frequencies in gnomAD
and/or in-house dataset. This result strengthened the association of
SCN4A with ET diagnosed in the Kurdish family. Considering that ET
is the most common movement disorder, it is not surprising that two
alleles of the proposed SCN4A variant are found in gnomAD. This
dataset also contains individuals with rare neuromuscular disorders.
Furthermore, we could also speculate that these two individuals might
have a nonpenetrant variant. Regarding the inheritance pattern of the
SCN4A variant in affected member IV-6, we hypothesize that it is a de
novo event, but this could not be assessed because IV-6's parents are
not available. Nevertheless, they were reported to have no symptoms
of essential tremor.
SCN4A has a well-established role in mediating the initiation and
propagation of electrical potential in muscle cells (Cannon, 2015). Sev-
eral gain-of-function variants of SCN4A have been known to underly
increased enhanced muscle excitability and manifest five different
allelic disorders—paramyotonia congenita, potassium-aggravated myo-
tonia, hyperkalemic periodic paralysis, hypokalemic periodic paralysis,
and congenital myasthenic syndrome (Xiuhai et al., 2008). Interest-
ingly, this channel protein, Nav1.4, was initially attributed to skeletal
muscle specific phenotypes, although its expression had been
observed both in mouse brain and human cerebral cortex, highlighting
its role in the brain (Bergareche et al., 2015). The congenital pheno-
type of ET in our cases and the previously reported Spanish cases
reflects its significance and indispensable role in normal brain
function.
Two of the previously reported substitutions of SCN4A are located
closely to the variant reported here; one of them, p.(Val1589Met),
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has been identified for Paramyotonia congenita of von Eulenburg
(Matthews et al., 2008) and the other one, p.(Met1592Val), is known
to be associated with both normokalemic and hyperkalemic periodic
paralysis (Figure 1c–e) (Rojas et al., 1991; Xiuhai et al., 2008). Both of
these mutations are described to influence the transmembrane helix
located next—spanning from 1575 to 1597 amino acids (Pan
et al., 2018)—to the one carrying our reported variant and thus explain
the variable clinical spectrum. Analyzing the location of these variants,
we found that p.Gly1537Ser, p.Val1589Met, and p.Met1592Val are
located along the ion channel, whereas Pro1560Leu is slightly more
distant (Figure 1e). This could potentially contribute to the different
clinical manifestations of these variants. Interestingly, one of these
variants, p.Gly1537Ser, has already been shown to affect ion flux
(Bergareche et al., 2015).
The channel, Nav1.4 interacts with the β1 subunit (Pan
et al., 2018). Subunit interactions usually stabilizes proteins against
proteolytic degradation that might be enhanced if the subunit interac-
tion is impaired. Furthermore, Pro in the loop position stabilizes the
loop conformation; given more flexibility, expected when having Leu
at that position, there is a greater possibility of increased proteolytic
degradation. Considering these facts, we may speculate that marked
reduction of SCN4A is most likely the consequence of proteolytic
degradation rather than impaired protein synthesis. Previously, it was
shown that impaired interaction of the alpha subunit of the voltage-
gated sodium channel (VGSC) with SCN1B (β1 subunit) impedes its
neuronal transport, where the β1 subunit was not translocated from
the soma to the axonal initial segments and nodes of Ranvier (Kruger
et al., 2016). These data suggest that neuronal transport of the β1
subunit is dependent on the formation of the α–β complex. We also
speculate that p.(Pro1560Leu) impairs the formation of the α–β com-
plex, thereby affecting the neuronal transport of the β1 subunit.
Our study strongly suggests the involvement of SCN4A in the eti-
ology of ET. We have shown that the identified variant of SCN4A
reduces the amount of protein and thus, haploinsufficiency of SCN4A
associated with a shortage of voltage-gated sodium channels may be
responsible for the disease phenotype. Furthermore, our data expand
the role of channelopathies to the etiology of ET.
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